
Keywords: HPS; hepatopulmonary syndrome; vWF-Ag; von Willebrand factor antigen; MELD; model for endstage-liver disease; IPVD; intrapulmonary vasodilation; vWF; von Willebrand factor; FEV1; forced expiratory volume in one second; FVC; forced vital capacity; AaPO2; a